ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $883,000 | +11.5% | 9,500 | -28.6% | 0.01% | +25.0% |
| Q3 2021 | $792,000 | -12.7% | 13,302 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $907,000 | -46.3% | 13,302 | -66.9% | 0.01% | -33.3% |
| Q1 2020 | $1,688,000 | -25.8% | 40,200 | -19.8% | 0.01% | -50.0% |
| Q4 2019 | $2,276,000 | +10.3% | 50,100 | +11.1% | 0.02% | +5.9% |
| Q3 2019 | $2,064,000 | -21.1% | 45,100 | +1.1% | 0.02% | -26.1% |
| Q2 2019 | $2,615,000 | – | 44,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |